Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users

Authors:
  • JMJosé M. Miró
    José M. Miró
  • ECEmilia Cortés
    Emilia Cortés
  • ACAna Cruceta
    Ana Cruceta
  • JMJordi Merce
    Jordi Merce
  • FMFrancesc Marco
    Francesc Marco
  • APAna Planes
    Ana Planes
  • JPJoan Carles Paré
    Joan Carles Paré
  • AMAsunción Moreno
    Asunción Moreno
  • IOImma Ocaña
    Imma Ocaña
  • JGJosé M. Gatell
    José M. Gatell
  • APAlbert Pahissa
    Albert Pahissa

Abstract
INFECTIVE ENDOCARDITIS (IE) is a classic complication of intravenous (IV) drug addiction. Since the first descriptions in the 1930s, the clinical pattern of IE in IV drug users has remained unchanged worldwide.1 Infectious endocarditis in IV drug users usually involves the tricuspid valve. It is usually caused by Staphylococcus aureus, and it has a relatively good prognosis. However, IV drug addiction is 1 of the most important risk factors for human immunodeficiency virus type 1 (HIV) infection. Currently, the prevalence of HIV infection among IV drug users with IE is very high, ranging from 44% to 90%.2-7 However, whereas the number of patients with acquired immunodeficiency syndrome (AIDS) among IV drug users dramatically increased in the 1990s, the incidence of IE in this population simultaneously decreased. Some authors have suggested that this decrease is due to changes in drug administration techniques to avoid HIV infection.1,8

This publication has 20 references indexed in Scilit: